237 related articles for article (PubMed ID: 21455993)
1. Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling.
Havelange V; Stauffer N; Heaphy CC; Volinia S; Andreeff M; Marcucci G; Croce CM; Garzon R
Cancer; 2011 Oct; 117(20):4696-706. PubMed ID: 21455993
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
[TBL] [Abstract][Full Text] [Related]
3. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.
Garzon R; Garofalo M; Martelli MP; Briesewitz R; Wang L; Fernandez-Cymering C; Volinia S; Liu CG; Schnittger S; Haferlach T; Liso A; Diverio D; Mancini M; Meloni G; Foa R; Martelli MF; Mecucci C; Croce CM; Falini B
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3945-50. PubMed ID: 18308931
[TBL] [Abstract][Full Text] [Related]
4. MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
Bao F; Zhang L; Pei X; Lian C; Liu Y; Tan H; Lei P
PLoS One; 2021; 16(9):e0256995. PubMed ID: 34587164
[TBL] [Abstract][Full Text] [Related]
5. Construction of a microRNA-mRNA Regulatory Network in
Esa E; Hashim AK; Mohamed EHM; Zakaria Z; Abu Hassan AN; Mat Yusoff Y; Kamaluddin NR; Abdul Rahman AZ; Chang KM; Mohamed R; Subbiah I; Jamian E; Ho CS; Lim SM; Lau PC; Pung YF; Zain SM
Genet Test Mol Biomarkers; 2021 Mar; 25(3):199-210. PubMed ID: 33734890
[No Abstract] [Full Text] [Related]
6. Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.
García-Ortí L; Cristóbal I; Cirauqui C; Guruceaga E; Marcotegui N; Calasanz MJ; Castello-Cros R; Odero MD
PLoS One; 2012; 7(10):e47717. PubMed ID: 23077663
[TBL] [Abstract][Full Text] [Related]
7. Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia.
Russ AC; Sander S; Lück SC; Lang KM; Bauer M; Rücker FG; Kestler HA; Schlenk RF; Döhner H; Holzmann K; Döhner K; Bullinger L
Haematologica; 2011 Dec; 96(12):1783-91. PubMed ID: 21880628
[TBL] [Abstract][Full Text] [Related]
8. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.
Jiang X; Huang H; Li Z; He C; Li Y; Chen P; Gurbuxani S; Arnovitz S; Hong GM; Price C; Ren H; Kunjamma RB; Neilly MB; Salat J; Wunderlich M; Slany RK; Zhang Y; Larson RA; Le Beau MM; Mulloy JC; Rowley JD; Chen J
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19397-402. PubMed ID: 23132946
[TBL] [Abstract][Full Text] [Related]
9. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
10. Identification of non-coding RNA regulatory networks in pediatric acute myeloid leukemia reveals circ-0004136 could promote cell proliferation by sponging miR-142.
Yuan DM; Ma J; Fang WB
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9251-9258. PubMed ID: 31773676
[TBL] [Abstract][Full Text] [Related]
11. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
12. miR-582-5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells.
Wang X; Feng Y; Zhang P; Chen H; Bai J; Wang F; He A
Cell Biol Int; 2020 Oct; 44(10):2021-2030. PubMed ID: 32543749
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 29b functions in acute myeloid leukemia.
Garzon R; Heaphy CE; Havelange V; Fabbri M; Volinia S; Tsao T; Zanesi N; Kornblau SM; Marcucci G; Calin GA; Andreeff M; Croce CM
Blood; 2009 Dec; 114(26):5331-41. PubMed ID: 19850741
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG).
Tian P; Yan L
Med Sci Monit; 2016 Dec; 22():5116-5123. PubMed ID: 28013316
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
16. miRNA-mRNA Profiling Reveals Prognostic Impact of
Gadewal N; Kumar R; Aher S; Gardane A; Gaur T; Varma AK; Khattry N; Hasan SK
Oncol Res; 2020 May; 28(3):321-330. PubMed ID: 32059753
[TBL] [Abstract][Full Text] [Related]
17. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis.
Debernardi S; Skoulakis S; Molloy G; Chaplin T; Dixon-McIver A; Young BD
Leukemia; 2007 May; 21(5):912-6. PubMed ID: 17330104
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
